ACombating SARS-CoV-2: leveraging microbicidal experiences with other emerging/re-emerging viruses
Raymond W. Nims (contributing author)
Process Analytical Technologies and Data Analytics for the Manufacture of Monoclonal Antibodies
Scott Rudge (co-author)
Assessing the Contributions of Inactivation, Removal, and Transfer of Ebola Virus and Vesicular Stomatitis Virus by Disinfectant Pre-soaked Wipes
Raymond W. Nims (contributing author)
Thermal Inactivation of Feline Calicivirus and Herpes Simplex Virus Type 1: Side-by-Side Suspension and Carrier Studies
Raymond W. Nims (contributing author)
Advances in BiochemicalEngineering/Biotechnology 171- Current Applications of Pharmaceutical Biotechnology
Scott Rudge (contributing author)
Cell Lines as Biological Models: Practical Steps for More Reliable Research
Capes-Davis, et al (Raymond W. Nims contributing author)
ICH Quality Guidelines: An Implementation Guide
Raymond W. Nims (Editor), Andrew Teasdale (Editor), David Elder (Editor)
Best practices for the use and evaluation of animal serum as a component of cell culture medium
Nims RW, Harbell JW
Single-use Systems for Biotechnology Products
Scott Rudge
Quality Risk Management
Scott Rudge
Applications for Transitions and Moment Analysis
Korben Knudson and Scott Rudge
Inactivation and Disinfection of Zika Virus on a Nonporous Surface
Cameron Wilde, Zheng Chen, Tanya Kapes, Cory Chiossone, Salimatu Lukula, Donna Suchmann, Raymond Nims, and S Steve Zhou
Research finds Zika virus can live for hours on hard, non-porous surfaces
Raymond W. Nims, S. Steve Zhou
Intra-family differences in efficacy of inactivation of small, non-enveloped viruses
Raymond W. Nims, S. Steve Zhou
Bioseparations Science and Engineering: 2nd Edition
Scott R. Rudge, Paul W. Todd, Demetri Petrides, Roger G. Harrison
Gamma Irradiation of Animal Serum: Validation of Efficacy for Pathogen Reduction and Assessment of Impacts on Serum Performance
Mark Plavsic, PhD, DVM, Raymond Nims, PhD, Marc Wintgens, and Rosemary J. Versteegen, PhD
Modeling the Efficacy of HTST for Inactivating Mouse Minute Virus
Plavsic, M. and Nims, R. W.
Contractor responsibilities in outsourced pharmaceutical quality control testing
Nims, R. W., and Meyers, E.
Overview of the nonclinical quality and toxicology testing for recombinant biopharmaceuticals produced in mammalian cells
Lebrec, H., Narayanan, P., and Nims, R.
USP <63> Mycoplasma Tests: A new regulation for mycoplasma testing
Nims, R. W., and Meyers, E.
Adventitious viruses detected in biopharmaceutical bulk harvest samples over a 10-year period
Kerr, A., and Nims, R.
Gamma-irradiation of serum for the inactivation of adventitious contaminants
Gauvin, G., and Nims, R.
Short tandem repeat profiling: part of an overall strategy for reducing the frequency of cell misidentification
Nims, R. W., Sykes, G., Cottrill, K., Ikonomi, P., and Elmore, E.
Authentication of human cell-based products: the role of a new consensus standard
Kerrigan, L., and Nims, R. W.
Non-tuberculosis mycobacterium contamination of a mammalian cell bioreactor process for biologics manufacture
Nims, R., Chun, A., Marino, A., and Dieringer-Boyer, S.
Adventitious viral contamination of biopharmaceuticals: Who is at risk?
Nims, R.
Gamma irradiation of animal sera for inactivation of viruses and mollicutes – a review
Nims, R. W., Gauvin, G., and Plavsic, M.
Circovirus inactivation – A literature review
Nims, R. W., and Plavsic, M.
Contractee Responsibilities in Outsourced Pharmaceutical Quality Control Testing
Raymond Nims and Elizabeth Meyers
Compliance Master PlansAre You Traveling Without One?
Timothy Joy, Scott Rudge, and Joanne Izyk
Controlled Environments
Multi-tenant Facilities for Biotech and Pharmaceutical Companies: Proactive landlords and developers savvy to life science concepts will attract tenants and share success. (Part I and Part II)
—Scott R. Rudge, Timothy G. Joy and Vicki Jenings
Sterilization
Steam Say Clean with Steam: Effective when saturated, steam is efficient and inexpensive, relative to other sterilization unit operations
—Scott Rudge